zetomipzomib
kezar
['lupus', '#0992', 'zetomipzomib', 'achieve,(-u achieve),(-u-achieve),(-uachieve)']
saxena et al zetomipzomib, a selective immunoproteasome inhibitor in lupus nephritis. phase 2 study. upcr=&lt;0.5 achieved 64.7% week 37, pred=&lt;10mg/day 82.4% week 13. #acr22 abstr#0992 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC